Literature DB >> 15009200

Antimicrobial activities of heparin-binding peptides.

Emma Andersson1, Victoria Rydengård, Andreas Sonesson, Matthias Mörgelin, Lars Björck, Artur Schmidtchen.   

Abstract

Antimicrobial peptides are effector molecules of the innate immune system. We recently showed that the human antimicrobial peptides alpha-defensin and LL-37 bind to glycosaminoglycans (heparin and dermatan sulphate). Here we demonstrate the obverse, i.e. structural motifs associated with heparin affinity (cationicity, amphipaticity, and consensus regions) may confer antimicrobial properties to a given peptide. Thus, heparin-binding peptides derived from laminin isoforms, von Willebrand factor, vitronectin, protein C inhibitor, and fibronectin, exerted antimicrobial activities against Gram-positive and Gram-negative bacteria. Similar results were obtained using heparin-binding peptides derived from complement factor C3 as well as consensus sequences for heparin-binding (Cardin and Weintraub motifs). These sequence motifs, and additional peptides, also killed the fungus Candida albicans. These data will have implications for the search for novel antimicrobial peptides and utilization of heparin-protein interactions should be helpful in the identification and purification of novel antimicrobial peptides from complex biological mixtures. Finally, consensus regions may serve as templates for de novo synthesis of novel antimicrobial molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009200     DOI: 10.1111/j.1432-1033.2004.04035.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  50 in total

1.  Collagen VI encodes antimicrobial activity: novel innate host defense properties of the extracellular matrix.

Authors:  Suado M Abdillahi; Selma Balvanović; Maria Baumgarten; Matthias Mörgelin
Journal:  J Innate Immun       Date:  2012-03-02       Impact factor: 7.349

2.  Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution.

Authors:  Sara L Svensson; Mukesh Pasupuleti; Björn Walse; Martin Malmsten; Matthias Mörgelin; Camilla Sjögren; Anders I Olin; Mattias Collin; Artur Schmidtchen; Ruth Palmer; Arne Egesten
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

3.  Activation of the complement system generates antibacterial peptides.

Authors:  Emma Andersson Nordahl; Victoria Rydengård; Patrik Nyberg; D Patric Nitsche; Matthias Mörgelin; Martin Malmsten; Lars Björck; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

Review 4.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 5.  Fragments of extracellular matrix as mediators of inflammation.

Authors:  Tracy L Adair-Kirk; Robert M Senior
Journal:  Int J Biochem Cell Biol       Date:  2007-12-24       Impact factor: 5.085

6.  Boosting antimicrobial peptides by hydrophobic oligopeptide end tags.

Authors:  Artur Schmidtchen; Mukesh Pasupuleti; Matthias Mörgelin; Mina Davoudi; Jan Alenfall; Anna Chalupka; Martin Malmsten
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

Review 7.  Midkine in host defence.

Authors:  A Gela; S Jovic; S L Nordin; A Egesten
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

8.  Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase.

Authors:  Mukesh Pasupuleti; Mina Davoudi; Martin Malmsten; Artur Schmidtchen
Journal:  BMC Res Notes       Date:  2009-07-15

9.  Antimicrobial activity of human prion protein is mediated by its N-terminal region.

Authors:  Mukesh Pasupuleti; Markus Roupe; Victoria Rydengård; Krystyna Surewicz; Witold K Surewicz; Anna Chalupka; Martin Malmsten; Ole E Sörensen; Artur Schmidtchen
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

10.  Protein C inhibitor--a novel antimicrobial agent.

Authors:  Erik Malmström; Matthias Mörgelin; Martin Malmsten; Linda Johansson; Anna Norrby-Teglund; Oonagh Shannon; Artur Schmidtchen; Joost C M Meijers; Heiko Herwald
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.